Mediphase Venture Partners

Mediphase Venture Partners is a venture capital firm specializing in early-stage investments within the life sciences sector, with a particular emphasis on biotechnology and pharmaceuticals. The firm seeks rapidly growing companies that present outstanding market opportunities, aiming to foster their development through active involvement.

The firm's investment strategy involves taking active roles in its portfolio companies, often joining their boards and collaborating closely with management to promote rapid growth. This hands-on approach is supported by the fund managers' unique combination of technical, operational, and investment experience, which is critical to the success of early-stage companies.

Over the years, Mediphase Venture Partners has built a diverse portfolio, including investments in companies such as Relypsa, Tetraphase Pharmaceuticals, Wellpartner, and Concert Pharmaceuticals. These investments reflect the firm's commitment to advancing innovative solutions in the healthcare and life sciences industries.